A detailed history of Retirement Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Retirement Group, LLC holds 1,691 shares of ABBV stock, worth $306,307. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,691
Previous 1,563 8.19%
Holding current value
$306,307
Previous $242,000 26.86%
% of portfolio
0.11%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $20,456 - $23,308
128 Added 8.19%
1,691 $307,000
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $3,339 - $3,866
-25 Reduced 1.57%
1,563 $232,000
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $168,876 - $202,527
1,221 Added 332.7%
1,588 $257,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $325,727 - $373,588
-2,427 Reduced 86.86%
367 $49,000
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $166,244 - $211,351
1,208 Added 76.17%
2,794 $428,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $2,243 - $2,783
17 Added 1.08%
1,586 $257,000
Q2 2021

Aug 17, 2021

SELL
$105.21 - $117.21 $15,991 - $17,815
-152 Reduced 8.83%
1,569 $177,000
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $10,843 - $11,937
106 Added 6.56%
1,721 $186,000
Q4 2020

Feb 22, 2021

BUY
$80.49 - $108.67 $103,671 - $139,966
1,288 Added 393.88%
1,615 $173,000
Q3 2020

Nov 16, 2021

SELL
$85.91 - $100.83 $2.15 Million - $2.53 Million
-25,052 Reduced 98.71%
327 $29,000
Q3 2020

Sep 08, 2021

BUY
$85.91 - $100.83 $2.16 Million - $2.53 Million
25,133 Added 10216.67%
25,379 $2.94 Million
Q2 2020

Sep 08, 2021

BUY
$73.37 - $98.18 $17,315 - $23,170
236 Added 2360.0%
246 $24,000
Q4 2019

Aug 30, 2021

BUY
$72.13 - $90.25 $721 - $902
10 New
10 $1,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.